Maternal transmission of GNAS1 mutations leads to AHO (characterized by short stature, obesity, skeletal defects and impaired olfaction) plus resistance to several hormones (e.g. parathyroid hormone) that activate Gsα in their target tissues. The gene discussed is GNAS; the disease is obesity disorder.